Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 5.68
(1.25%)
CNY 5.68
(1.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -520.12 Million CNY | -68.24% |
| 2022 | -309.16 Million CNY | 41.48% |
| 2021 | -528.34 Million CNY | -11.4% |
| 2020 | -474.25 Million CNY | -435.76% |
| 2019 | 141.24 Million CNY | 1000.7% |
| 2018 | 12.83 Million CNY | -93.52% |
| 2017 | 197.97 Million CNY | -12.69% |
| 2016 | 226.76 Million CNY | 61.23% |
| 2015 | 140.64 Million CNY | 219.9% |
| 2014 | -117.3 Million CNY | 78.93% |
| 2013 | -556.62 Million CNY | 54.36% |
| 2012 | -1.21 Billion CNY | 8.66% |
| 2011 | -1.33 Billion CNY | -3296.21% |
| 2010 | -39.3 Million CNY | -344.43% |
| 2009 | 16.08 Million CNY | 149.31% |
| 2008 | -32.61 Million CNY | -43.12% |
| 2007 | -22.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -524.22 Million CNY | 16.53% |
| 2024 Q3 | -617.43 Million CNY | -17.78% |
| 2024 Q1 | -628.03 Million CNY | -20.75% |
| 2023 Q3 | -444.66 Million CNY | -256.83% |
| 2023 Q2 | -124.61 Million CNY | 26.54% |
| 2023 FY | -520.12 Million CNY | -68.24% |
| 2023 Q1 | -169.63 Million CNY | 45.13% |
| 2023 Q4 | -520.12 Million CNY | -16.97% |
| 2022 Q4 | -309.16 Million CNY | 13.71% |
| 2022 Q2 | -416.7 Million CNY | 33.61% |
| 2022 FY | -309.16 Million CNY | 41.48% |
| 2022 Q1 | -627.68 Million CNY | -18.8% |
| 2022 Q3 | -358.29 Million CNY | 14.02% |
| 2021 Q3 | -485.03 Million CNY | -7.81% |
| 2021 Q1 | -420.94 Million CNY | 11.24% |
| 2021 FY | -528.34 Million CNY | -11.4% |
| 2021 Q4 | -528.34 Million CNY | -8.93% |
| 2021 Q2 | -449.91 Million CNY | -6.88% |
| 2020 Q2 | -122.07 Million CNY | 25.7% |
| 2020 Q4 | -474.25 Million CNY | -61.11% |
| 2020 Q1 | -164.29 Million CNY | -216.32% |
| 2020 FY | -474.25 Million CNY | -435.76% |
| 2020 Q3 | -294.36 Million CNY | -141.13% |
| 2019 Q1 | 166.49 Million CNY | 1197.43% |
| 2019 Q4 | 141.24 Million CNY | -40.17% |
| 2019 Q3 | 236.08 Million CNY | -26.19% |
| 2019 Q2 | 319.85 Million CNY | 92.11% |
| 2019 FY | 141.24 Million CNY | 1000.7% |
| 2018 Q3 | 278.49 Million CNY | 8.47% |
| 2018 FY | 12.83 Million CNY | -93.52% |
| 2018 Q2 | 256.75 Million CNY | 13.25% |
| 2018 Q1 | 226.7 Million CNY | 14.51% |
| 2018 Q4 | 12.83 Million CNY | -95.39% |
| 2017 Q3 | 188.05 Million CNY | -44.21% |
| 2017 Q1 | 290.48 Million CNY | 28.1% |
| 2017 FY | 197.97 Million CNY | -12.69% |
| 2017 Q2 | 337.06 Million CNY | 16.03% |
| 2017 Q4 | 197.97 Million CNY | 5.28% |
| 2016 Q2 | 148.83 Million CNY | -52.36% |
| 2016 FY | 226.76 Million CNY | 61.23% |
| 2016 Q1 | 312.44 Million CNY | 122.15% |
| 2016 Q3 | 215.43 Million CNY | 44.75% |
| 2016 Q4 | 226.76 Million CNY | 5.26% |
| 2015 Q4 | 140.64 Million CNY | -28.62% |
| 2015 Q3 | 197.05 Million CNY | 974.33% |
| 2015 FY | 140.64 Million CNY | 219.9% |
| 2015 Q1 | -228.05 Million CNY | -94.42% |
| 2015 Q2 | 18.34 Million CNY | 108.04% |
| 2014 Q3 | -144.42 Million CNY | 12.21% |
| 2014 FY | -117.3 Million CNY | 78.93% |
| 2014 Q4 | -117.3 Million CNY | 18.78% |
| 2014 Q2 | -164.5 Million CNY | 81.29% |
| 2014 Q1 | -879.2 Million CNY | -57.95% |
| 2013 Q3 | -611.58 Million CNY | 12.28% |
| 2013 Q4 | -556.62 Million CNY | 8.99% |
| 2013 FY | -556.62 Million CNY | 54.36% |
| 2013 Q1 | -1.02 Billion CNY | 15.88% |
| 2013 Q2 | -697.18 Million CNY | 32.03% |
| 2012 Q3 | -1.2 Billion CNY | -2.06% |
| 2012 FY | -1.21 Billion CNY | 8.66% |
| 2012 Q1 | -1.39 Billion CNY | -4.14% |
| 2012 Q2 | -1.18 Billion CNY | 14.97% |
| 2012 Q4 | -1.21 Billion CNY | -1.07% |
| 2011 Q2 | -1.28 Billion CNY | 1.14% |
| 2011 FY | -1.33 Billion CNY | -3296.21% |
| 2011 Q1 | -1.29 Billion CNY | -3201.66% |
| 2011 Q3 | -1.27 Billion CNY | 0.66% |
| 2011 Q4 | -1.33 Billion CNY | -4.75% |
| 2010 Q3 | 1.96 Million CNY | 102.58% |
| 2010 FY | -39.3 Million CNY | -344.43% |
| 2010 Q2 | -76.38 Million CNY | 0.0% |
| 2010 Q4 | -39.3 Million CNY | -2098.14% |
| 2009 FY | 16.08 Million CNY | 149.31% |
| 2009 Q4 | 16.08 Million CNY | 0.0% |
| 2008 FY | -32.61 Million CNY | -43.12% |
| 2007 FY | -22.78 Million CNY | 0.0% |